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THE TAY-SACHS DISEASE
SCREENING PROGRAM IN THE
U.S. AS A MODEL FOR THE
CONTROL OF GENETIC DISEASE:
AN HISTORICAL VIEW
Paul J. Edelson, M.D.t
TAY-SACHS DISEASE IS A HEREDITARY disorder
of the central nervous system in which symptoms develop
within the first six months of life and which end fatally three
to four years later. Apparently normal at birth, most children
with Tay-Sachs Disease will begin to show definite signs of
neurologic deterioration sometime in their first year of life.
Once symptoms develop, the course is considered one of inex-
orable decline. Blindness, seizures, profound mental retarda-
tion, and death develop before age five.'
The disease was first described in 1881 by Dr. Warren
Tay, an English physician.2 It was more fully described by Dr.
Bernard Sachs, a neurologist at Mt. Sinai Hospital in New
York City who reported on a pair of affected siblings in 1887,
and, more definitively, in 1896.? Dr. Sachs, a Harvard gradu-
ate, named the condition "amaurotic familial idiocy," the name
being derived from the Greek term for blindness.4
t Chair, Department of Pediatrics, New York Methodist Hospital, Brooklyn.
1. See generally Howard R. Sloan & Donald S. Fredrickson, GM2 Gnagliosidoses: Tay-
Sachs Disease, in THE METABOLIC BASIS OF INHERITED DISEASE 615 (John B. Stanbury et al.
eds., 1972).
2. See Warren Tay, Symmetrical Changes in the Region of the Yellow Spot in Each Eye of
an Infant, TRANSACTIONS OPHTHALMOLOGICAL SOC'Y U.K., Apr. 1881, at 55-56 (describing the
physiological effects of Tay-Sachs Disease for the first time).
3. See Bernard Sachs, On Arrested Cerebral Development, with Special Reference to its
Cortical Pathology, 14 J. NERVOUS & MENTAL DISEASE 541, 543-53 (1887); Bernard Sachs, A
Family Form of Idiocy, Generally Fatal, Associated with Early Blindness, 21 J. NERVOUS &
MENTAL DISEASE 475-79 (1896) [hereinafter A Family Form ofIdiocy].
4. A Family Form of Idiocy, supra note 3, at 475.
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Over the next eighty years, Tay-Sachs Disease was recog-
nized as a rare, but recurring disease occurring primarily, but
not exclusively, in descendants of Eastern European
(Ashkenazi) Jews. Primarily, the disease was found in individu-
als from Kovno, Suwalik, and certain other provinces in North-
eastern Poland which had been included in the Russified "Jew-
ish Pale of Settlement.,
5
As Dr. Howard Markel described in this symposium,6 the
1880s saw an epic migration of Jewish families from Russia to
cities in North America. These immigrants were first driven by
cholera, and then by outbreaks of anti-Semitic violence in
Russia and Russian Poland. Over the decade, more than a
million people emigrated to New York, Montreal, Boston, and
other Atlantic ports. Indeed, it is likely that Dr. Sachs' patients
were born to one of these displaced Russian Jewish families.
As the Ashkenazi community grew, so did the number of
cases of Tay-Sachs Disease. By the mid-1950s, a ward at the
Jewish Hospital for Chronic Diseases in Brooklyn, New York
was devoted entirely to the care of children with Tay-Sachs
Disease and similar conditions. To aid this work, a group of
parents of children with Tay-Sachs Disease formed the Nation-
al Tay-Sachs and Allied Diseases Association. This Association
helped to establish the Isaac Albert Research Institute at the
hospital to support research into the cause and treatment of the
disease.'
By the mid-1960s, Tay-Sachs Disease was recognized as
one of several conditions, including Niemann-Pick and Gaucher
Diseases, where the absence of a normal degradative enzyme
allows the accumulation of cellular waste components which
over time intrude on, and eventually destroy, normal organ
function. Such "storage diseases," as they came to be known,
5. See generally Arlene L. Fraikor, An Anthropological Analysis of Tay-Sachs Disease:
Genetic Drift Among the Ashkenazim Jews (1973) (Ph.D. dissertation, University of Colorado) (on
file with the University of South Carolina Libraries) (describing the cultural connection between
Tay-Sachs disease and Ashkenazim Jews).
6. See generally Howard Markel, Di Goldine Medina (The Golden Land): Historical
Perspectives ofEugenics and the East European (Ashkenazi) Jewish-American Community, 1880-
1925,7 HEALTH MATRIX 49 (1997).
7. See Judith Saperstein, The National Tay-Sachs andAllied Diseases Association, Inc., in
TAY-SACHS DIsEASE: SCREENING AND PREVENTION 9,9-10 (Michael M. Kabach et a. eds., 1977)
(discussing the history of the National Tay-Sachs and Allied Diseases Association).
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were objects of intense scientific investigation in the 1960s and
1970s.8 In 1971, John O'Brien and Shintaro Okada developed
an assay for the so-called Tay-Sachs enzyme, Hexosaminidase
A (Hex A). Hex A could identify not only affected individuals
themselves, each of whose two copies of the Hex A gene had
the Tay-Sachs mutation, but also the healthy heterozygous
parents who were known as "carders." Carriers each possess a
single copy of the abnormal gene, and as a result had half the
normal levels of Hex A.9 Because even half-normal enzyme
levels are sufficient to allow normal function, it is only when
two "carrier" parents have a child who receives the Tay-Sachs
gene from each that the disease occurs. Thus, by screening
people for the "carrier" condition, and in this way identifying
couples at risk for having children with Tay-Sachs Disease, it
is theoretically possible to prevent the birth of affected chil-
dren.
By 1973, the National Tay-Sachs Foundation had a new
goal -- to control Tay-Sachs Disease by promoting carrier
screening. In 1975, Ms. Judith Saperstein, President of the
Foundation, stated the goal in her address to the First Interna-
tional Conference on Tay-Sachs Disease sponsored by the
Foundation:
Since the start of this decade, when carrier identification and
prenatal diagnosis became a reality, our organization has shifted
its emphasis somewhat away from scientific research - which
no longer really needs us to the extent it once did, as it now
has its own momentum and interest - and more to education,
screening, and prevention."
Thus, from the very beginning, many people took as axi-
omatic that screening programs could and would work to pre-
vent Tay-Sachs Disease, and to a great extent, therefore, the
8. See generally Shintaro Okada et al., Ganglioside GM2 Storage Diseases:
Hexosaminidase Deficiencies in Cultured Fibroblasts, 23 AM. J. HUM. GENETICS 55, 55-61
(1971).
9. See Shintaro Okada & John S. O'Brien, Tay-Sachs Disease: Generalized Absence of a
Beta-D-N-Acetylhexosaminidase Component, 165 SCIENCE 698, 698-700 (1969) (presenting
results of a study concluding that hexosaminidase assay can be used to diagnose individuals
homozygotic for Tay-Sachs disease); John S. O'Brien et al., Tay-Sachs Disease: Detection of
Heterozygotes and Homozygotes by Serum Hexosaminidase Assay, 283 NEW ENG. J. MED. 15, 15-
20 (1970) (explaining the genetic transfer of Tay-Sachs and the early identification of the disease).
10. See Saperstein, The National Tay-Sachs and Allied Diseases Association, Inc., in TAY-
SACHS DISEASE: SCREENING AND PREVENTON, supra note 7, at 9-10.
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problem of Tay-Sachs Disease was now solved. Furthermore,
many scientists declared, even before much experience with
screening had been accumulated, let alone digested and ana-
lyzed, that Tay-Sachs screening was not only a great success in
its own right, but also that it could serve as a model for other
screening programs for genetic disorders."
While there is evidence that the Tay-Sachs programs have
been effective in educating people about their risks of having
children affected by the disease, and perhaps even some evi-
dence suggesting that these programs have led to a decline in
the birth rate of children with Tay-Sachs Disease, a careful
reading of the historical record suggests that Tay-Sachs screen-
ing has not been the unqualified success it has sometimes been
described to have been. Moreover, the Tay-Sachs Model may
not necessarily be the most appropriate model to use in design-
ing programs for the control of other genetic diseases.
The approach taken to screening for Tay-Sachs Disease
carriers was based on three notions: (i) that Tay-Sachs Disease
is a rare disease in the general population, occurring in perhaps
1:360,000 births; (ii) that it is perhaps one hundred times more
common among Ashkenazi-Jewish families (about 1:3,600
births); and (iii) that the disease could only be controlled by
affecting the reproductive decisions of couples at risk for hav-
ing affected children. Therefore, programs were developed
which were primarily aimed at young Ashkenazi-Jewish mar-
ried couples who had not yet completed their families. The
programs were organized on a community by community basis,
usually stimulated by academic physicians at a local institution
who had professional interests in Tay-Sachs Disease.
Although the programs were often supported by both
public and private funds, 2 the programs were nearly always
carried out under the auspices of local Jewish community
11. See generally Michael M. Kaback & Robert S. Zeiger, Heterozygote Detection in Tay-
Sachs Disease: A Prototype Community Screening Program for the Prevention of Recessive
Genetic Disorders, in ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 628-30 (Bruno W.
Volk & Stanley M. Aronson eds., 1972) (explaining the use of Tay-Sachs screening as a model for
other screening programs).
12. See Michael M. Kaback et al., Tay-Sachs Disease: Heterozygote Screening and Prena-
tal Diagnosis-U.S. Experience and World Experience, in TAY-SACHs DISEASE: SCREENING AND
PREVENTION 16-17 (Michael M. Kaback et al. eds., 1977) (demonstrating the breakdown of
funding for Tay-Sachs screening programs).
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groups.'3 These groups were often both financial and social
sponsors of the programs as well as important sources of vol-
unteer workers. Jewish women's groups were especially impor-
tant in the effort.
Most programs spent a considerable amount of time in
educational activities, even before the actual screening sessions
began. These activities involved not only efforts to acquaint the
Jewish community with the nature of Tay-Sachs Disease, but
also more "politically" inclined efforts to recruit the support of
lay, and more importantly, religious leaders of all the principal
sects - Conservative, Reformed, Orthodox, and Hasidic. Such
early discussions laid the ground work for the public an-
nouncement of the screening campaigns and protected the
programs from public controversy over the relation of screen-
ing to abortion - an issue on which each of the principal
religious groupings took a somewhat different position.
In the first ten years of the screening program, over
100,000 people were screened in the United States, and slightly
over 4,000 carriers of the Tay-Sachs gene were identified.
World-wide, 124 at-risk couples were identified. Furthermore,
through 1976, ninety pregnancies of such couples were moni-
tored, of which twenty-one, which test results identified as
affected, were terminated, and sixty-seven unaffected off-spring
were born. One unaffected pregnancy "spontaneously" aborted
one week after amniocentesis was performed. In addition, in
one case an infant was born who had been erroneously diag-
nosed as unaffected, but who later developed Tay-Sachs Dis-
ease.
Despite these generally positive aggregate statistics, specif-
ic U.S. programs, as well as certain programs in other coun-
tries, were not as successful. Some programs had poor commu-
nity responses, like the one in Honolulu, where of an estimated
60,000 Jewish residents, only seventy showed up for Tay-Sachs
screening, or the British experience in which despite efforts to
encourage mass screening among the 400,000 members of the
13. See David V. McQueen, Social Aspects of Genetic Screening for Tay-Sachs Disease:
The Pilot Community Screening Program in Baltimore and Washington, 22 SOC. BIOLOGY 125,
125-33 (1975) (discussing the role of the Jewish community in the pilot Tay-Sachs Disease
screening program).
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Jewish community, fewer than 400 persons were tested. 14 In-
deed, even for the United States as a whole, only about ten
percent of the estimated target population of more than one
million, participated in Tay-Sachs screening.
Perhaps a more concerning outcome than the failure to
reach appropriate persons for screening, was the screening of
less appropriate groups, for example, high school students too
young to be planning families and persons whose families were
already complete. The Montreal program specifically focused
on high school and college students for screening."' Unlike
most of the U.S. programs in which married persons predomi-
nated, in this group only thirty-four percent of those screened
were married. Although participation rates were considerably
better than those among programs targeting couples (about
seventy-five percent), follow-up studies indicated that though
knowledge about Tay-Sachs Disease generally rose with partic-
ipation in screening, among high school students who were
identified as "carriers," nearly half felt "worried," or "de-
pressed" by the information shortly after testing, and about
one-third still felt "worried" or "depressed" up to seventeen
months later.
Perhaps rather than debating the extent to which Tay-
Sachs screening programs were successful in the 1970s, a more
interesting historical question is why, after the "eugenic" pro-
grams of the Nazi state, post-war Jewish communities would
be interested in even considering participation in a program
which would identify what some would have called a "race-
based" genetic "defect" present among Eastern European Jews.
This is particularly intriguing because it would lead, albeit
selectively, to the abortion of Jewish pregnancies.
Several reasons have been offered for the willingness of so
many persons in the Jewish community to participate in Tay-
14. See Charles R. Scriver & Reynold J.M. Gold, Tay-Sachs Heterozygote Screening:
Specificity and Sensitivity, in TAY-SACHS DisEASE: SCREENING AND PREVENTION, 239-43
(Michael M. Kaback et al. eds., 1977) (stating that screening tests sort out apparently well persons
who probably have a [trait] from those who do not).
15. See Carol L. Clow & Charles R. Scriver, The Adolescent Copes with Genetic Screen-
ing: A Study of Tay-Sachs Screening Among High-School Students, in TAY-SACHS DisEASE:
SCREENING AND PREVENTION 381, 381-93 (Michael M. Kaback et al. eds., 1977) (discussing
genetic testing of high school students for genetic predisposition to Tay-Sachs Disease).
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Sachs screening. Some commentators have suggested that the
nature of the disease itself has driven the interest in screening.
While this may have been an important motivation in some
participants, particularly individuals with a family history of
Tay-Sachs Disease, surveys show a large percentage of partici-
pants in screening programs to have been essentially unin-
formed about the nature of Tay-Sachs Disease.16 Others have
suggested that higher educational levels in a community gener-
ally translate into greater cooperation with mass screening
programs. However, there is little, if any, data which actually
examines this idea. Furthermore, the information that is avail-
able, principally from work done on participants in the Los
Angeles screening program, suggests that other factors, particu-
larly gender, played a much greater role in motivating coopera-
tion.
I would suggest that application of the historian's concept
of how a disease is "framed"' 7 may be a more fruitful ap-
proach to understanding the surprising acceptance of Tay-Sachs
screening by the American-Jewish community. From the begin-
ning, this community has been deeply involved in defining the
nature and meaning of Tay-Sachs Disease. Jewish physicians
had been active in diagnosing and treating cases, and in deter-
mining the prevalence of the Tay-Sachs mutation in the Jewish
population. Likewise, Jewish medical and philanthropic institu-
tions, and perhaps most importantly, voluntary associations,
were centrally involved in developing not only the scientific,
but also the social understanding of this condition. This, pre-
sumably, has led to a characterization of the birth of a child
with Tay-Sachs Disease as a personal and family tragedy, to be
avoided if possible, rather than as a fault for which blame
should be assigned to the infant's "carrier" parents.
For the scientists involved, rather than a disease of amor-
phous, even protean characteristics, hard to recognize at first
16. See Fred Massarik et al., Community-Based Genetic Education, Community Channels,
and Knowledge of Tay-Sachs Disease, in TAY-SACHS DIsEASE: SCREENING AND PREVENTION
353, 359 (Michael M. Kaback et al. eds., 1977) (discussing the level of knowledge held by people
of different educational training with respect to Tay-Sachs Disease).
17. See generally FRAMING DISEASE: STUDIES IN CULTURAL HISTORY (Charles E.
Rosenberg & Janet Golden eds., 1992) (explaining that disease has both social and biological ele-
ments).
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and always difficult to distinguish from clinically and in some
cases biochemically similar conditions, Tay-Sachs Disease has
been repeatedly pictured as a highly distinctive condition with
an almost stereotyped clinical and pathological appearance.
Little attention has been drawn to the need for careful interpre-
tation of what can in many cases be ambiguous or misleading
test results, researchers preferring to emphasize the nearly
"automatic" nature of the screening test, and insisting on, even
when discussing occasional, but tragic errors resulting from its
use, its almost absolute reliability. 8
In so far as there were complex religious and moral issues
raised by a strategy which depends primarily upon selective
abortion to control the prevalence of this dreaded disease, it is
important to appreciate that screening has been interpreted as
offering "carrier" couples the chance to have unaffected chil-
dren, and crediting the birth of healthy offspring to these cou-
ples as a positive outcome of the programs. By interpreting
screening programs in this way, not only is it easier to gain
rabbinical support, but it also makes it easier to focus on
young married couples as the principal targets of screening
because they are the most likely group to want such informa-
tion.
Lastly, there has been a general acceptance that biochemi-
cal, or more recently, gene-based diagnosis of Tay-Sachs Dis-
ease is uniformly correlated with a malignant and ultimately
fatal clinical course.
Given such a "frame," it no longer seems quite as surpris-
ing that Tay-Sachs screening would be widely accepted by the
American Jewish community. However, such key characteris-
tics as the tight coupling between diagnosis and clinical out-
come, the clear implications for specific action which the iden-
tification of "carrier" status has, and the relatively brief and
well-defined time span within which persons have to act with
regard to this information, all seem to be essential to the
programs' successes.
To the extent that other diseases are framed differently,
address a very different target audience, or have very different
18. See Kaback & Zeiger, supra note 11, at 22-23 (suggesting that Tay-Sachs screening
tests, although good, do not produce exact results all the time).
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functional characteristics, it would seem that those diseases
would be less likely to benefit from many of the factors lead-
ing to successes in Tay-Sachs screening. Instead, it seems
prudent to consider that any attempt to apply the "lessons" of
Tay-Sachs screening needs to be done in a very cautious and
highly nuanced way, with much attention to the specific details
of the situations being analogized.
I would like to end with a cautionary word of advice
originally offered by Albert Einstein with regard to the science
of relativity, but which I think can be profitably applied to the
task of designing a safe and effective program to use informa-
tion from BRCA1 testing. It goes something like this:
Everything should be made as simple as possible - but no
simpler.

